Celgene Gives Reassurances That Key Products And Programs Remain On Track

Celgene's quarterly earnings call was all about reassuring investors that its products and pipeline will deliver the full value of...

More From BioPortfolio on "Celgene Gives Reassurances That Key Products And Programs Remain On Track"